tiprankstipranks
eWeLL Co.,Ltd (JP:5038)
:5038
Japanese Market
Want to see JP:5038 full AI Analyst Report?

eWeLL Co.,Ltd (5038) AI Stock Analysis

0 Followers

Top Page

JP:5038

eWeLL Co.,Ltd

(5038)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 5.2)
Rating:72Outperform
Price Target:
¥2,664.00
▲(0.45% Upside)
Action:Reiterated
Date:02/18/26
Strong financial performance (excellent profitability, debt-free balance sheet, and good cash conversion) is the primary driver of the score. This is offset by weak technical momentum (below key moving averages with negative MACD) and a valuation that is not cheap (P/E ~31.6 with a low dividend yield).
Positive Factors
Multi-year revenue growth
Sustained, multi-year revenue expansion shows durable product-market fit and scaling capacity. Growing top line from ~0.79B to ~3.39B supports reinvestment, economies of scale and resilience in medium term, aiding long-term margin and cash generation stability.
Negative Factors
Growth deceleration
A material slowdown from prior higher growth rates toward ~14% suggests the business may be maturing or facing tougher market comps. Persistently lower growth would limit operating leverage benefits and could pressure long-term return expansion absent new product or market catalysts.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-year revenue growth
Sustained, multi-year revenue expansion shows durable product-market fit and scaling capacity. Growing top line from ~0.79B to ~3.39B supports reinvestment, economies of scale and resilience in medium term, aiding long-term margin and cash generation stability.
Read all positive factors

eWeLL Co.,Ltd (5038) vs. iShares MSCI Japan ETF (EWJ)

eWeLL Co.,Ltd Business Overview & Revenue Model

Company Description
eWeLL Co.,Ltd. develops business support cloud services for visiting nursing stations in Japan. It also provides iBow, a SaaS-type business support tool that contributes to improving customer productivity; iBow receipt, a receipt system exclusivel...
How the Company Makes Money
null...

eWeLL Co.,Ltd Financial Statement Overview

Summary
High-quality fundamentals: strong multi-year revenue growth, best-in-class margins (2025 net margin ~32%, EBIT margin ~45%), debt-free balance sheet, and solid cash conversion (operating cash flow exceeds net income). Main risk is noticeable revenue growth deceleration in 2025 (~14%).
Income Statement
92
Very Positive
Balance Sheet
95
Very Positive
Cash Flow
88
Very Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.97B3.39B2.57B2.07B1.60B1.19B
Gross Profit2.35B2.65B1.94B1.60B1.26B969.51M
EBITDA1.48B1.64B1.22B967.84M725.48M414.60M
Net Income990.39M1.09B808.26M612.90M449.56M340.29M
Balance Sheet
Total Assets3.52B4.28B3.10B2.41B1.65B1.06B
Cash, Cash Equivalents and Short-Term Investments2.22B2.86B1.97B1.41B1.08B617.07M
Total Debt0.000.000.0091.50M96.06M180.62M
Total Liabilities701.16M908.43M687.05M719.78M544.97M557.12M
Stockholders Equity2.82B3.38B2.41B1.69B1.11B504.15M
Cash Flow
Free Cash Flow0.001.23B839.09M440.68M527.34M347.06M
Operating Cash Flow0.001.27B856.79M626.91M543.38M408.64M
Investing Cash Flow0.00-210.38M-77.89M-217.84M-136.43M-73.75M
Financing Cash Flow0.00-168.38M-225.88M-71.36M51.19M-44.56M

eWeLL Co.,Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2652.00
Price Trends
50DMA
2066.34
Negative
100DMA
2289.49
Negative
200DMA
2485.42
Negative
Market Momentum
MACD
-43.65
Positive
RSI
40.48
Neutral
STOCH
46.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5038, the sentiment is Negative. The current price of 2652 is above the 20-day moving average (MA) of 2001.15, above the 50-day MA of 2066.34, and above the 200-day MA of 2485.42, indicating a bearish trend. The MACD of -43.65 indicates Positive momentum. The RSI at 40.48 is Neutral, neither overbought nor oversold. The STOCH value of 46.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:5038.

eWeLL Co.,Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
¥29.11B25.300.47%30.58%23.45%
71
Outperform
¥17.96B17.763.14%-3.85%-17.22%
70
Outperform
¥23.49B7.224.58%6.58%35.23%
64
Neutral
¥32.43B15.6232.07%349.54%
60
Neutral
¥6.18B20.7518.87%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
¥30.94B36.7918.09%-50.60%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:5038
eWeLL Co.,Ltd
1,906.00
-515.12
-21.28%
JP:3835
eBASE Co., Ltd.
390.00
-99.48
-20.32%
JP:4397
TeamSpirit, Inc.
374.00
-57.00
-13.23%
JP:4477
BASE, Inc.
275.00
-118.18
-30.06%
JP:5027
AnyMind Group Inc.
504.00
-101.08
-16.71%
JP:9629
PCA Corporation
1,243.00
-437.04
-26.01%

eWeLL Co.,Ltd Corporate Events

eWeLL Posts Strong Q1 Growth on iBow Demand and AI Scheduling Uptake
May 25, 2026
eWeLL Co., Ltd. reported a 26.5% year-on-year increase in first-quarter net sales to JPY953 million, driven by rising demand for its iBow service and strong uptake of legal training ahead of the fiscal year-end among home-visit nursing operators. ...
eWeLL Delivers Strong Q1 2026 Earnings and Plans Higher Dividend
May 14, 2026
eWeLL Co., Ltd. reported strong non-consolidated results for the first quarter ended March 31, 2026, with net sales rising 26.5% year on year to ¥953 million and net income increasing 16.5% to ¥305 million. Profitability remained high, w...
eWeLL Beats FY2025 Forecasts as It Prepares Medium-Term Growth Push
Mar 13, 2026
eWeLL reported strong results for the fiscal year ended December 2025, with fourth-quarter net sales rising 31.9% year on year and operating profit up 35.3%, both exceeding its earnings forecasts. The operating profit margin reached 45.3%, and alt...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026